<SEC-DOCUMENT>0000320017-21-000087.txt : 20210630
<SEC-HEADER>0000320017-21-000087.hdr.sgml : 20210630
<ACCEPTANCE-DATETIME>20210630160753
ACCESSION NUMBER:		0000320017-21-000087
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20210630
DATE AS OF CHANGE:		20210630
EFFECTIVENESS DATE:		20210630

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CALADRIUS BIOSCIENCES, INC.
		CENTRAL INDEX KEY:			0000320017
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				222343568
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-257560
		FILM NUMBER:		211062010

	BUSINESS ADDRESS:	
		STREET 1:		110 ALLEN ROAD
		STREET 2:		SECOND FLOOR
		CITY:			BASKING RIDGE
		STATE:			NJ
		ZIP:			07920
		BUSINESS PHONE:		908-842-0100

	MAIL ADDRESS:	
		STREET 1:		110 ALLEN ROAD
		STREET 2:		SECOND FLOOR
		CITY:			BASKING RIDGE
		STATE:			NJ
		ZIP:			07920

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Caladrius Biosciences, Inc.
		DATE OF NAME CHANGE:	20150608

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NeoStem, Inc.
		DATE OF NAME CHANGE:	20060906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHASE III MEDICAL INC/DE
		DATE OF NAME CHANGE:	20030819
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>forms-8june2021.htm
<DESCRIPTION>S-8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i075f82c7a82a4a3cb62d8cea6874fa43_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">As filed with the Securities and Exchange Commission on June&#160;30, 2021</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Registration No. 333-</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">______________________________________________________________________________________________________</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FORM S-8</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CALADRIUS BIOSCIENCES, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">                 &#160;&#160;&#160;&#160;&#160;&#160;&#160;                 Delaware</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;           &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">22-2343568</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                             (State or other jurisdiction&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(I.R.S. employer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                         of incorporation or organization)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;identification number)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">110 Allen Road, Second Floor</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basking Ridge, NJ&#160;07920</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices&#59; zip code)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Caladrius Biosciences, Inc. 2018 Equity Incentive Compensation Plan, as amended </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (Full title of the plan)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Todd C. Girolamo, Esq.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Chief Legal Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Senior Vice President, Corporate Development</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Caladrius Biosciences, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">800 Westchester Avenue</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Suite N341</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Rye Brook, NY 10573</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(212) 584-4180</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Name, address and telephone number, including area code, of agent for service)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Large accelerated filer&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;              Accelerated filer &#160;</font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-accelerated filer&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smaller reporting company &#160;</font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.&#160;</font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">CALCULATION OF REGISTRATION FEE</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of Securities to be Registered</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount to be Registered (1)(2)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proposed Maximum Offering Price Per Share (3)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proposed Maximum Aggregate Offering Price (3)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Registration Fee</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Common Stock, $0.001 par value per share </font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,000,000</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$1.63</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$9,780,000</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$1,067.00</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.34pt">Pursuant to General Instruction E to Form S-8, this Registration Statement registers an additional 6,000,000 shares of the registrant's common stock, par value $.001 per share (&#8220;Common Stock&#8221;), issuable pursuant to the 2018 Equity Incentive Compensation Plan (as amended, the &#8220;2018 Equity Plan&#8221;). The registrant has previously registered on Form S-8 (File No.333-248101) 1,000,000 shares of Common Stock issuable pursuant to the 2018 Plan. Following the filing of this Registration Statement, there will be an aggregate of 8,500,000 shares of Common Stock registered and authorized for issuance pursuant to the 2018 Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">In accordance with Rule 416 under the Securities Act of 1933, as amended (the &#34;Securities Act&#34;), this Registration Statement also covers such indeterminate number of additional shares as may be issuable pursuant to the 2018 Equity Plan, to prevent dilution resulting from any equity restructuring or change in capitalization of the registrant, including, but not limited to, spin offs, stock dividends, large non-recurring dividends, rights offerings, stock splits or similar transactions. Also includes rights to acquire Common Stock or preferred stock under any shareholder rights plan in effect from time to time, if applicable, under the terms of any such plan.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">Estimated, in accordance with Rule 457(c) and Rule 457(h)(1) of the Securities Act, solely for the purpose of calculating the registration fee. The proposed maximum offering price per share and the proposed maximum aggregate offering price are based on the average of the high and low prices for a share of Common Stock on the Nasdaq Capital Market on June&#160;28, 2021, which is a date within five business days prior to the date of this registration statement.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i075f82c7a82a4a3cb62d8cea6874fa43_4"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PART&#160;I</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">INFORMATION REQUIRED IN THE SECTION&#160;10(a)&#160;PROSPECTUS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The information required to be contained in the Section 10(a) prospectus is omitted from this registration statement and will be provided to participants in the 2018 Equity Plan pursuant to Rule&#160;428&#160;of the Securities Act of 1933, as amended (the &#34;Securities Act&#34;), and the note to Part I of Form S-8.</font></div><div><font><br></font></div><div id="i075f82c7a82a4a3cb62d8cea6874fa43_7"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PART II</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 3. Incorporation of Certain Documents by Reference.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Securities and Exchange Commission (the &#34;SEC&#34;) allows us to incorporate into this registration statement information we file with other documents. This means we may disclose important information to you by referring to other documents that contain that information. The information incorporated by reference is considered to be part of this registration statement, and information we file later with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below, except to the extent information in those documents is different from the information contained in this registration statement&#58;</font></div><div style="text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.65pt">Our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 25, 2021 (File No. 001-33650)&#59; </font></div><div style="padding-left:49.5pt;text-align:justify"><font><br></font></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.65pt">Our Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, filed with the SEC on May 6, 2021 (File No. 001-33650)&#59;</font></div><div style="padding-left:49.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.65pt">Our Current Reports on Form 8-K filed with the SEC on January 25, 2021, February 16, 2021, March 19, 2021, June 4, 2021 and June 16, 2021 (File Nos. 001-33650) &#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.65pt">The description of the Common Stock contained in the Registration Statement on Form 8-A filed with the SEC on August 2, 2013 (including any amendment or report filed with the SEC for the purpose of updating that description) (File No. 001-33650).</font></div><div style="padding-left:49.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All documents (other than current reports, or portions thereof, furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items) subsequently filed by us with the SEC pursuant to Sections 13(a), 13(c), 14 and 15(d)&#160;of the Exchange Act, prior to the filing of a post-effective amendment to this registration statement, which indicates that all securities offered hereby have been sold or which de-registers all securities then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be part hereof from the date of filing of such reports and documents. </font></div><div style="text-align:justify;text-indent:24.75pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Description of Securities.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Not applicable.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Interest of Named Experts and Counsel.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The validity of the issuance of the shares of Common Stock registered under this Registration Statement has been passed upon the Registrant by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. A member of that firm owns 1,000 shares of Common Stock of the Registrant.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 6.&#160;Indemnification of Directors and Officers.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Registrant was incorporated under the laws of the State of Delaware. Under the General Corporation Law of the State of Delaware (the &#8220;Delaware GCL&#8221;), a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), by reason of the fact that he or she is or was the Registrant&#8217;s director, officer, employee or agent, or is or was serving at the Registrant&#8217;s request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the Registrant&#8217;s best interests, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.</font></div><div style="text-align:justify;text-indent:24.75pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, the Delaware GCL also provides that the Registrant also may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the Registrant&#8217;s right to procure a judgment in its favor by reason of the fact that he or she is or was the Registrant&#8217;s director, officer, employee or agent, or is or was serving at the Registrant&#8217;s request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys&#8217; fees) actually and reasonably incurred by him or her in connection with the defense or settlement of such action or suit if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the Registrant&#8217;s best interests. However, in such an action by or on the Registrant&#8217;s behalf, no indemnification may be made in respect of any claim, issue or matter as to which the person is adjudged liable to the Registrant unless and only to the extent that the court determines that, despite the adjudication of liability but in view of all the circumstances, the person is fairly and reasonably entitled to indemnity for such expenses which the court shall deem proper.</font></div><div style="text-align:justify;text-indent:24.75pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Registrant&#8217;s certificate of incorporation is consistent with the Delaware GCL. Each of the Registrant&#8217;s directors, officers, employees and agents will be indemnified to the extent permitted by the Delaware GCL. The Registrant also maintains insurance on behalf of its directors and officers against liabilities asserted against such persons and incurred by such persons in such capacities, whether or not the Registrant would have the power to indemnify such persons under the Delaware GCL.</font></div><div style="text-align:justify;text-indent:24.75pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Registrant has entered into indemnification agreements with its Chief Executive Officer and Chief Financial Officer, and certain other employees and each of the Registrant&#8217;s directors pursuant to which the Registrant has agreed to indemnify such party to the full extent permitted by law, subject to certain exceptions, if such party becomes subject to an action because such party is the Registrant&#8217;s director, officer, employee, agent or fiduciary.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to such other rights of indemnification as they may have, the 2018 Equity Plan contains the following indemnification provisions applicable to (i) each member of the Board of Directors of the Company and (ii) each member of the committee which administers the 2018 Equity Plan (the &#34;Committee&#34;), defined as the Compensation Committee of the Board of Directors, or such other committee of members of the Board appointed by the Board, authorized under Section 14 of the 2018 Equity Plan to administer the 2018 Equity Plan and to perform the functions assigned to the Committee under such 2018 Equity Plan&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;The Plan shall be administered by the Committee. The Committee shall have full and exclusive discretionary authority to construe, interpret and apply the terms of the Plan, to determine eligibility and to adjudicate all disputed claims filed under the Plan. Every finding, decision and determination made by the Committee shall, to the full extent permitted by the law, be final and binding upon all parties. The Committee may retain the services of an outside firm to serve as its agent in administering the Plan on a day-to-day basis. No member of the Board or the Committee shall be liable for any act done or omitted to be done by such member or by any other member of the Board or the Committee in connection with the Plan, except for such member's own willful misconduct or as expressly provided by statute.&#34;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exemption from Registration Claimed.</font></div><div style="text-align:justify;text-indent:24.75pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Not applicable.</font></div><div style="text-align:justify;text-indent:24.75pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 8. Exhibits.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The exhibits accompanying this registration statement are listed on the accompanying exhibit index. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Undertakings.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The undersigned Registrant hereby undertakes&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement&#58;</font></div><div style="padding-left:58.5pt;text-align:justify"><font><br></font></div><div style="padding-left:45pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.57pt">To include any prospectus required by section 10(a)(3) of the Securities Act&#59;</font></div><div style="padding-left:9pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) promulgated under the Securities Act if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement&#59;</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.03pt">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in this Registration Statement.</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i075f82c7a82a4a3cb62d8cea6874fa43_10"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">SIGNATURES</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Basking Ridge (Bernards Township),, State of New Jersey, on this 30th day of June 2021.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:234pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">CALADRIUS BIOSCIENCES, INC.</font></div><div style="padding-left:234pt;text-align:justify"><font><br></font></div><div style="padding-left:234pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; David J. Mazzo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:234pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; David J. Mazzo, PhD</font></div><div style="padding-left:234pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;   President and Chief Executive Officer</font></div><div style="padding-left:234pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)</font></div><div style="padding-left:234pt;text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:234pt;text-align:justify"><font><br></font></div><div style="padding-left:234pt;text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below under the heading &#34;Signature&#34; constitutes and appoints David J. Mazzo and Todd C. Girolamo or either of them, his true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities to sign any and all amendments (including post-effective amendments) to this registration statement and any related registration statement filed under Rule 462(b), and to file the same, with all exhibits thereto and other documents in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully for all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated&#58;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:31.479%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.207%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Title</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Date</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; David J. Mazzo</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">David J. Mazzo, PhD</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Director, President and Chief Executive Officer  (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">June 30, 2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Gregory B. Brown</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gregory B. Brown, MD</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chairman of the Board of Directors</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">June 30, 2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Michael H. Davidson</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br>Michael H. Davidson, MD</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">June 30, 2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Steven M. Klosk</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Steven M. Klosk</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">June 30, 2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Steven S. Myers</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Steven S. Myers</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">June 30, 2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Cynthia S. Schwalm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br>Cynthia S. Schwalm</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">June 30, 2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Peter G. Traber</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Peter G. Traber, MD</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">June 30, 2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Anne C. Whitaker</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Anne C. Whitaker</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">June 30, 2021</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i075f82c7a82a4a3cb62d8cea6874fa43_13"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Description</font></div><div><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:40.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:16.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:448.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/320017/000032001716000143/exhibit31arcertofincorpeff.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">3.1</a></font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Certificate of Incorporation, as amended, incorporated by reference to Exhibit 3.1 of Registrants Quarterly Report on Form 10-Q, filed with the SEC on August 9, 2016.</font></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/320017/000032001716000143/exhibit32arbylawseff072720.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">3.2</a></font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Bylaws, as amended, incorporated by reference to Exhibit 3.2 of the Registrant's Quarterly Report on Form 10-Q, filed with the SEC on August 9, 2016.</font></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/320017/000032001717000082/exhibit31092017.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">3.3</a></font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to the Amended and Restated Bylaws, as amended, incorporated by reference to Exhibit 3.1 of the Registrant's Current Report on Form 8-K, filed with the SEC on September 21, 2017.</font></td></tr><tr style="height:17pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/320017/000032001721000056/def14a-2021.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">4.1</a></font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Caladrius Biosciences, Inc. 2018 Equity Incentive Compensation Plan, as amended, effective June 16, 2021.</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="ex51tos-8june2021.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5.1</a></font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="ex51tos-8june2021.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">23.1</a></font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., (included in Exhibit 5.1)</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="ex232toforms-8june2021.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">23.2</a></font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Grant Thornton LLP, independent registered public accounting firm</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i075f82c7a82a4a3cb62d8cea6874fa43_10" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">24.1</a></font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power of Attorney (included on the signature pages of this registration statement)</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________</font></div><div><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:522.00pt"><tr><td style="width:1.0pt"></td><td style="width:16.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:502.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">             </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ex51tos-8june2021.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i28364a66f71e4114aeb653023c4410d5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 5.1</font></div><div><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"><tr><td style="width:1.0pt"></td><td style="width:348.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:151.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:63pt"><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="mintza.jpg" src="mintza.jpg" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:64px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chrysler Center<br>666 Third Avenue<br>New York, NY  10017<br>212-935-3000<br>212-983-3115 fax <br>www.mintz.com</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:360pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">June 30, 2021</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Caladrius Biosciences, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">110 Allen Road, Second Floor</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Basking Ridge, NJ 07920</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">We have acted as counsel to Caladrius Biosciences, Inc., a Delaware corporation (the &#8220;Company&#8221;), in connection with the preparation and filing with the Securities and Exchange Commission of a Registration Statement on Form S&#8209;8 (the &#8220;Registration Statement&#8221;), pursuant to which the Company is registering the issuance under the Securities Act of 1933, as amended, of a total of 6,000,000 shares (the &#8220;Shares&#8221;) of its common stock, $0.001 par value per share (the &#8220;Common Stock&#8221;), that may be issued pursuant to the Caladrius Biosciences Inc. 2018 Equity Incentive Compensation Plan (as amended, the &#8220;Plan&#8221;). This opinion is being rendered in connection with the filing of the Registration Statement. All capitalized terms used herein and not otherwise defined shall have the respective meanings given to them in the Registration Statement.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">In connection with this opinion, we have examined the Company&#8217;s Amended and Restated Certificate of Incorporation, as amended, and Amended and Restated Bylaws, as amended, both as currently in effect&#59; such other records of the corporate proceedings of the Company and certificates of the Company&#8217;s officers as we have deemed relevant&#59; and the Registration Statement and the exhibits thereto.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">In our examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified or photostatic copies and the authenticity of the originals of such copies. In addition, we have assumed that the Company will receive any required consideration in accordance with the terms of the Plan.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Based upon the foregoing, we are of the opinion that (i) the Shares have been duly and validly authorized by the Company and (ii) the Shares, when sold and delivered in accordance with the terms of the Plan, will have been duly and validly issued, fully paid and non&#8209;assessable shares of the Common Stock, free of preemptive rights.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">Our opinion is limited to the applicable provisions of the United States federal laws and the state laws of the State of Delaware, and we express no opinion with respect to the laws of any other jurisdiction. No opinion is expressed herein with respect to the qualification of the Shares under the securities or blue sky laws of any state or any foreign jurisdiction.</font></div><div><font><br></font></div><div style="text-indent:24.75pt"><font><br></font></div><div style="text-indent:24.75pt"><font><br></font></div><div style="text-indent:24.75pt"><font><br></font></div><div style="text-indent:24.75pt"><font><br></font></div><div style="text-align:center;text-indent:24.75pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:700;line-height:112%">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:9pt;font-weight:400;line-height:112%">Boston &#124; London &#124; Los Angeles &#124; New York &#124; San Diego &#124; San Francisco &#124; Stamford &#124; Washington</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">June  30, 2021</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 2</font></div><div style="text-indent:24.75pt"><font><br></font></div><div style="text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">We understand that you wish to file this opinion as an exhibit to the Registration Statement in accordance with the requirements of Item 601(b)(5) of Regulation S-K promulgated under the Securities Act, and we hereby consent thereto. In giving this consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.</font></div><div style="text-indent:24.75pt"><font><br></font></div><div style="text-indent:24.75pt"><font><br></font></div><div style="text-indent:24.75pt"><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Very truly yours,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>ex232toforms-8june2021.htm
<DESCRIPTION>EX-23.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7d622b3af86541b89cea93ef485735ce_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 23.2</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We have issued our report dated</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">February 25, 2021 with respect to the consolidated financial statements of Caladrius Biosciences, Inc. included in the Annual Report on Form 10-K for the year ended December 31, 2020, which is incorporated by reference in this Registration Statement. We consent to the incorporation by reference of the aforementioned report in this Registration Statement. </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> &#47;s&#47; GRANT THORNTON LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">New York, New York</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">June 30, 2021</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>mintza.jpg
<TEXT>
begin 644 mintza.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #R +X# 2(  A$! Q$!_\0
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M2M6^,GQ-\3>-]<D+ZGKM]+>RIYC.L(9ODA0L2=D:;44'HJJ.U<A110 4444
M%%:?AOP_J'B[Q#I>AZ1:O?:KJ=U%96=K&,M--(X1$'N68 ?6MSXO>"$^&7Q8
M\:>#X[EKU/#VM7NDK=,NTS""=XMY'8G9G'O0!R%%%% !6]X-_P"0G+_UQ/\
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M:7X,ZAIW_!-G_@GMI_B_7-,CO/%NN3PZC/IC2M"]U=W17RK;<R90Q6R NN"
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M\4:SXBUB?[5JVKWLVH7D^T+YDTKF21L#@99B>* /U>_X)J>,-*_:C_9#\=?
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M\9:IX;_MZ\;4)=-M;1)HXYGP9F#.V?GD+R8Z#?@< "N*_P"'(/@[_HI^N?\
M@NA_^*H _(:OIG_@G5\$E^.?[5WA+3[J!9]&T)CXAU-&"LK0V[(41E/#*\S0
M(P_NNU?<'_#D'P=_T4_7/_!=#_\ %5]-_L;_ +$/AO\ 8YM?$QTC6[SQ%J&O
M/!YUY?0I&8XH@VR-%7.,M(Y)SS\O]V@#Z4HHHH **** "OYK/VL?^3IOC)_V
M.>L_^ETU?TIU^>GQ-_X(]^%OB=\2?%OC"Y^(NL65QXAU>[U:2VBL(F2%IYWE
M**2V2%+XSWQ0!^,5%?KS_P .0?!W_13]<_\ !=#_ /%4?\.0?!W_ $4_7/\
MP70__%4 ?D-6]X-_Y"<O_7$_^A+7ZM_\.0?!W_13]<_\%T/_ ,55K3?^"*?A
M/2YVEC^)NLDLNWY]-A]0?[WM0!^DM%%% !1110 4444 %%%% !1110 4444
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M?\$9?^33-5_[&J\_])[6O1_^"H?_ "8K\3?IIO\ Z<[6O./^",O_ ":9JO\
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M445P7QP^,OA_X _"W7O'GB>61-*TF'S#%"NZ6XD8A8X8Q_>=V51G@9R2 "0
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':/2BB@#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
